LEX Diagnostics is a medical device company that specializes in molecular diagnostics for primary care. Having solved the PCR cost problem, LEX focuses tightly on nasal and oral samples, and on viral pathogens, to avoid the other high-cost elements of traditional molecular diagnostic products. LEX Diagnostics is a spin-out from TTP plc, atechnology development company in the life science and medical device sector. The origins of the LEX technology lie in an internal R&D project to reduce the time it takes to get a result from a PCR test. It formed a company when it became clear the solution also reduced the cost and size of any diagnostic device using it.LEX Diagnostics was founded in 2020 and is based in Melbourn, United Kingdom.

Biotechnology

Health Care

Health Diagnostics

LEX Diagnostics

Ed Farrell

Lucie Matejikova

Elliott Spain

Tim Schuller

Heather Danks (nee Murton)

Chris Hole

Andrew Anyakwo

Amaru Araya-Williams

The Engineering and Manufacturing team at LEX Diagnostics is responsible for the design, development, and production of innovative diagnostic devices that leverage cost-effective PCR technologies. This team focuses on optimizing manufacturing processes, ensuring high-quality production of cartridges, and integrating engineering solutions to enhance the performance and reliability of molecular diagnostic products tailored for primary care. Their expertise drives the advancement of LEX's mission to provide accessible and efficient diagnostic solutions for viral pathogens.

Engineering and Manufacturing

Research and Development

Leadership Team

Engineering and Manufacturing

About

Team members

Other teams at LEX Diagnostics

Research and Development

Leadership Team